In Vivo Genome-Wide Binding Interactions of Mouse and Human Constitutive Androstane Receptors Reveal Novel Gene Targets Ben Niu1, Denise M

Total Page:16

File Type:pdf, Size:1020Kb

In Vivo Genome-Wide Binding Interactions of Mouse and Human Constitutive Androstane Receptors Reveal Novel Gene Targets Ben Niu1, Denise M Published online 8 August 2018 Nucleic Acids Research, 2018, Vol. 46, No. 16 8385–8403 doi: 10.1093/nar/gky692 In vivo genome-wide binding interactions of mouse and human constitutive androstane receptors reveal novel gene targets Ben Niu1, Denise M. Coslo1, Alain R. Bataille2, Istvan Albert2, B. Franklin Pugh2 and Curtis J. Omiecinski1,* 1Center for Molecular Toxicology and Carcinogenesis, Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA 16802, USA and 2Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, PA 16802, USA Received May 04, 2018; Revised July 17, 2018; Editorial Decision July 19, 2018; Accepted July 20, 2018 ABSTRACT tion factors that are activated by direct ligands (1) and gen- erally share a common structure, an N-terminal A/B do- The constitutive androstane receptor (CAR; NR1I3) main, a DNA binding domain (DBD), a hinge domain, a is a nuclear receptor orchestrating complex roles ligand binding/ heterodimerization domain (LBD) and an in cell and systems biology. Species differences in F domain at the C-terminal (2). Upon ligand activation, CAR’s effector pathways remain poorly understood, the LBD would utilize activation function-2 (AF-2) to me- including its role in regulating liver tumor promotion. diate co-regulator interactions (3). However, CAR is dis- We developed transgenic mouse models to assess tinguished from other nuclear receptors in that it lacks an genome-wide binding of mouse and human CAR, A/B domain and is constitutively active in the absence of following receptor activation in liver with direct lig- ligand due to a charge-charge interaction between LBD he- ands and with phenobarbital, an indirect CAR acti- lixes that mimic an active AF-2 conformation, and therefore vator. Genomic interaction profiles were integrated capable of co-activator protein interactions in the absence of ligand (4). with transcriptional and biological pathway analyses. CAR was initially characterized as a xenobiotic Newly identified CAR target genes included Gdf15 metabolism modulator. Classified as a Class II nuclear re- and Foxo3, important regulators of the carcinogenic ceptor, another unusual property of CAR is its retention in process. Approximately 1000 genes exhibited dif- the cytosol in a phosphorylated state, but upon xenobiotic ferential binding interactions between mouse and sensing, it undergoes dephosphorylation, translocates into human CAR, including the proto-oncogenes, Myc the nucleus, and subsequently binds specific DNA motifs to and Ikbke, which demonstrated preferential bind- coordinately regulate transcription of target genes. Targets ing by mouse CAR as well as mouse CAR-selective include genes that encode drug metabolizing functions, transcriptional enhancement. The ChIP-exo analyses such as the Phase I cytochrome P450s, Phase II transferases also identified distinct binding motifs for the respec- and Phase III transporters (5–7). With respect to its role tive mouse and human receptors. Together, the re- in xenobiotic regulation, CAR contributes to regulating the metabolism of approximately 75% of clinically used sults provide new insights into the important roles drugs and is a major determinant in the detoxification of that CAR contributes as a key modulator of numer- environmental chemicals (6). Consequently, CAR is of ous signaling pathways in mammalian organisms, toxicological importance in safety evaluations for drug presenting a genomic context that specifies species discovery and in the development of industrial chemicals variation in biological processes under CAR’s con- destined for regulatory approval. trol, including liver cell proliferation and tumor pro- More recent evidence identified CAR’s broader roles motion. in regulating energy and lipid metabolism, cell prolifer- ation and carcinogenesis (6). For example, CAR is re- INTRODUCTION ported to suppress gluconeogenesis through its target- ing of genes such as phosphoenolpyruvate carboxykinase The constitutive androstane receptor (CAR) is a nuclear (PEPCK;PCK1) and glucose-6-phosphatase (G6PC), and receptor member (NR1I3) of the nuclear receptor super- functions to reverse induced-obesity in rodent models by family. Typically, nuclear receptors function as transcrip- *To whom correspondence should be addressed. Tel: +1 814 863 1625; Fax: +1 814 863 1696; Email: [email protected] C The Author(s) 2018. Published by Oxford University Press on behalf of Nucleic Acids Research. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact [email protected] 8386 Nucleic Acids Research, 2018, Vol. 46, No. 16 regulating genes such as sterol regulatory element bind- (Clontech/Takara, Mountain View, CA, USA) to gener- ing protein 1 (SREBP1;SREBF1) (8). Studies of liver tu- ate yellow fluorescent protein N-terminal fusion CAR pro- morigenesis promoted by phenobarbital (PB) and 1,4-bis[2- tein constructs (YFP-hCAR and YFP-mCAR). All con- (3,5-dichloropyridyloxy)] benzene (TCPOBOP; TCP) re- structs were validated by DNA sequencing. Adenovirus vealed that CAR is essential for hepatic tumor progression (AV) constructs containing YFP-hCAR, YFP-mCAR and in initiation-promotion mouse models (9,10). Further stud- YFP-empty were produced in the Adeno X Expression Sys- ies have demonstrated that CAR induces growth arrest and tem (Clontech/Takara) and amplified to high titer by Sig- DNA-damage-inducible beta (GADD45B) and myelocyto- naGen (Rockville, MD, USA). blastosis oncogene (MYC), while altering microRNA ex- pression profiles related to hepatocarcinogenesis (11–13). Animals and treatments However, detailed roles for CAR’s participation in the car- cinogenic process are not well understood and are the sub- All animal care and experimental procedures complied with ject of some controversy in that chronic human exposures protocols approved by the Institutional Animal Care and to PB, a known CAR activator, have not been associated Use Committee of The Pennsylvania State University.Wild- with any detectable increase in human liver cancer incidence type (WT) C57BL/6 mice were purchased from Charles (14,15). Adding to its overall complexity, another unique River Laboratories (Wilmington, MA). Breeding pairs of feature of CAR among the nuclear receptors is that its ac- CAR -/- /pregnane X receptor (PXR) -/- double-knockout tivation pathways proceed through both direct ligand inter- (DBL KO) mice in the C57BL/6 background were a kind actions and through indirect signaling mechanisms (5,16). gift of Dr. Wen Xie (University of Pittsburg, Pittsburg, PA), The potential receptor conformational alterations inherent and their derivation was described previously (18). CAR in these respective activation pathways may result in differ- knockout (CAR -/-; CAR KO) mice were generated by ences in CAR genomic targeting, or in biological/ signal- crossing WT C57BL/6 mice with DBL KO mice. The mice ing outcomes, areas that have not been well characterized. were maintained under a standard 12 h light, 12 h dark cy- We hypothesized that differing DNA interaction profiles for cle at constant temperature (23 ± 1◦C) with 45–65% humid- the respective species CAR proteins, and perhaps variable ity. A total of six, 8-week-old male CAR -/- mice were in- chemical activation states, underlie the transcriptional pro- fected with YFP-hCAR AV (1 × 1012 virus particles/ml, grams driving differences in CAR’s biological function. ∼100 ul diluted injection volume per mouse) through tail- Due to technical limitations and poor availability of vein injection. At 72 and 94 h, the mice were administrated a chromatin immunoprecipitation (ChIP)-grade antibody, with two successive doses of PB (75mg/kg, in saline) (n = high-resolution genomic mapping for CAR has not been 3), or CITCO (5 mg/kg, in DMSO) (n = 3), through IP in- performed in vivo. In this investigation, we deployed ChIP- jection. Another six, 8-week-old male CAR -/- mice were exo, a modified ChIP-seq method incorporating exonucle- infected with YFP-mCAR AV constructs (1 × 1012 virus ase to trim crosslinking ChIP DNA (17), combined with particles/ml) through tail-vein injection. At 72 and 94 h, CAR-fusion proteins and a novel delivery system, to con- two successive doses of PB (75 mg/kg, in saline) (n = 3), duct high resolution, genome scale profiling for mouse and or TCPOBOP (2 mg/kg, in DMSO) (n = 3), were admin- human CAR (mCAR and hCAR) in vivo, using transgenic istrated. After 96 h, all AV-infected mice were harvested mouse models. With a view toward better definition of the for liver tissues after CO2 asphyxiation-induced euthanasia. role of CAR in carcinogenesis, we identified novel CAR ge- For non-adenovirus infected mice, 8-week-old male CAR - nomic interactions, referenced to published RNA-seq tran- /- mice (n = 6) and WT mice (n = 6) were administrated with scriptomic datasets. Further, we assessed CAR’s genomic a single dose of DMSO (4 ml/kg) (n = 3) or TCPOBOP interactions in the presence of direct vs. indirect activators, (2 mg/kg, in DMSO) (n = 3), through IP injection. After performed DNA motif analyses, assessed species differences 24 h, liver tissue extractions were performed following CO2 in CAR genomic binding profiles and identified specific
Recommended publications
  • Analysis of Trans Esnps Infers Regulatory Network Architecture
    Analysis of trans eSNPs infers regulatory network architecture Anat Kreimer Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2014 © 2014 Anat Kreimer All rights reserved ABSTRACT Analysis of trans eSNPs infers regulatory network architecture Anat Kreimer eSNPs are genetic variants associated with transcript expression levels. The characteristics of such variants highlight their importance and present a unique opportunity for studying gene regulation. eSNPs affect most genes and their cell type specificity can shed light on different processes that are activated in each cell. They can identify functional variants by connecting SNPs that are implicated in disease to a molecular mechanism. Examining eSNPs that are associated with distal genes can provide insights regarding the inference of regulatory networks but also presents challenges due to the high statistical burden of multiple testing. Such association studies allow: simultaneous investigation of many gene expression phenotypes without assuming any prior knowledge and identification of unknown regulators of gene expression while uncovering directionality. This thesis will focus on such distal eSNPs to map regulatory interactions between different loci and expose the architecture of the regulatory network defined by such interactions. We develop novel computational approaches and apply them to genetics-genomics data in human. We go beyond pairwise interactions to define network motifs, including regulatory modules and bi-fan structures, showing them to be prevalent in real data and exposing distinct attributes of such arrangements. We project eSNP associations onto a protein-protein interaction network to expose topological properties of eSNPs and their targets and highlight different modes of distal regulation.
    [Show full text]
  • Identification of the Binding Partners for Hspb2 and Cryab Reveals
    Brigham Young University BYU ScholarsArchive Theses and Dissertations 2013-12-12 Identification of the Binding arP tners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactions and Non- Redundant Roles for Small Heat Shock Proteins Kelsey Murphey Langston Brigham Young University - Provo Follow this and additional works at: https://scholarsarchive.byu.edu/etd Part of the Microbiology Commons BYU ScholarsArchive Citation Langston, Kelsey Murphey, "Identification of the Binding Partners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactions and Non-Redundant Roles for Small Heat Shock Proteins" (2013). Theses and Dissertations. 3822. https://scholarsarchive.byu.edu/etd/3822 This Thesis is brought to you for free and open access by BYU ScholarsArchive. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of BYU ScholarsArchive. For more information, please contact [email protected], [email protected]. Identification of the Binding Partners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactions and Non-Redundant Roles for Small Heat Shock Proteins Kelsey Langston A thesis submitted to the faculty of Brigham Young University in partial fulfillment of the requirements for the degree of Master of Science Julianne H. Grose, Chair William R. McCleary Brian Poole Department of Microbiology and Molecular Biology Brigham Young University December 2013 Copyright © 2013 Kelsey Langston All Rights Reserved ABSTRACT Identification of the Binding Partners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactors and Non-Redundant Roles for Small Heat Shock Proteins Kelsey Langston Department of Microbiology and Molecular Biology, BYU Master of Science Small Heat Shock Proteins (sHSP) are molecular chaperones that play protective roles in cell survival and have been shown to possess chaperone activity.
    [Show full text]
  • Gene Expression Studies: from Case-Control to Multiple-Population-Based Studies
    From the Institute of Human Genetics, Helmholtz Zentrum Munchen,¨ Deutsches Forschungszentrum fur¨ Gesundheit und Umwelt (GmbH) Head: Prof. Dr. Thomas Meitinger Gene expression studies: From case-control to multiple-population-based studies Thesis Submitted for a Doctoral Degree in Natural Sciences at the Faculty of Medicine, Ludwig-Maximilians-Universitat¨ Munchen¨ Katharina Schramm Dachau, Germany 2016 With approval of the Faculty of Medicine Ludwig-Maximilians-Universit¨atM ¨unchen Supervisor/Examiner: Prof. Dr. Thomas Illig Co-Examiners: Prof. Dr. Roland Kappler Dean: Prof. Dr. med. dent. Reinhard Hickel Date of oral examination: 22.12.2016 II Dedicated to my family. III Abstract Recent technological developments allow genome-wide scans of gene expression levels. The reduction of costs and increasing parallelization of processing enable the quantification of 47,000 transcripts in up to twelve samples on a single microarray. Thereby the data collec- tion of large population-based studies was improved. During my PhD, I first developed a workflow for the statistical analyses of case-control stu- dies of up to 50 samples. With large population-based data sets generated I established a pipeline for quality control, data preprocessing and correction for confounders, which re- sulted in substantially improved data. In total, I processed more than 3,000 genome-wide expression profiles using the generated pipeline. With 993 whole blood samples from the population-based KORA (Cooperative Health Research in the Region of Augsburg) study we established one of the largest population-based resource. Using this data set we contributed to a number of transcriptome-wide association studies within national (MetaXpress) and international (CHARGE) consortia.
    [Show full text]
  • Noninvasive Sleep Monitoring in Large-Scale Screening of Knock-Out Mice
    bioRxiv preprint doi: https://doi.org/10.1101/517680; this version posted January 11, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. Noninvasive sleep monitoring in large-scale screening of knock-out mice reveals novel sleep-related genes Shreyas S. Joshi1*, Mansi Sethi1*, Martin Striz1, Neil Cole2, James M. Denegre2, Jennifer Ryan2, Michael E. Lhamon3, Anuj Agarwal3, Steve Murray2, Robert E. Braun2, David W. Fardo4, Vivek Kumar2, Kevin D. Donohue3,5, Sridhar Sunderam6, Elissa J. Chesler2, Karen L. Svenson2, Bruce F. O'Hara1,3 1Dept. of Biology, University of Kentucky, Lexington, KY 40506, USA, 2The Jackson Laboratory, Bar Harbor, ME 04609, USA, 3Signal solutions, LLC, Lexington, KY 40503, USA, 4Dept. of Biostatistics, University of Kentucky, Lexington, KY 40536, USA, 5Dept. of Electrical and Computer Engineering, University of Kentucky, Lexington, KY 40506, USA. 6Dept. of Biomedical Engineering, University of Kentucky, Lexington, KY 40506, USA. *These authors contributed equally Address for correspondence and proofs: Shreyas S. Joshi, Ph.D. Dept. of Biology University of Kentucky 675 Rose Street 101 Morgan Building Lexington, KY 40506 U.S.A. Phone: (859) 257-2805 FAX: (859) 257-1717 Email: [email protected] Running title: Sleep changes in knockout mice bioRxiv preprint doi: https://doi.org/10.1101/517680; this version posted January 11, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • Human Blastocysts of Normal and Abnormal Karyotypes Display Distinct Transcriptome Profles Received: 16 March 2018 Frederick Licciardi1, Tenzin Lhakhang2, Yael G
    www.nature.com/scientificreports OPEN Human blastocysts of normal and abnormal karyotypes display distinct transcriptome profles Received: 16 March 2018 Frederick Licciardi1, Tenzin Lhakhang2, Yael G. Kramer3, Yutong Zhang4, Adriana Heguy4,5,6 & Accepted: 26 September 2018 Aristotelis Tsirigos 2,5,6 Published: xx xx xxxx Unveiling the transcriptome of human blastocysts can provide a wealth of important information regarding early embryonic ontology. Comparing the mRNA production of embryos with normal and abnormal karyotypes allows for a deeper understanding of the protein pathways leading to viability and aberrant fetal development. In addition, identifying transcripts specifc for normal or abnormal chromosome copy number could aid in the search for secreted substances that could be used to non- invasively identify embryos best suited for IVF embryo transfer. Using RNA-seq, we characterized the transcriptome of 71 normally developing human blastocysts that were karyotypically normal vs. trisomic or monosomic. Every monosomy and trisomy of the autosomal and sex chromosomes were evaluated, mostly in duplicate. We frst mapped the transcriptome of three normal embryos and found that a common core of more than 3,000 genes is expressed in all embryos. These genes represent pathways related to actively dividing cells, such as ribosome biogenesis and function, spliceosome, oxidative phosphorylation, cell cycle and metabolic pathways. We then compared transcriptome profles of aneuploid embryos to those of normal embryos. We observed that non-viable embryos had a large number of dysregulated genes, some showing a hundred-fold diference in expression. On the contrary, sex chromosome abnormalities, XO and XXX displayed transcriptomes more closely mimicking those embryos with 23 normal chromosome pairs.
    [Show full text]
  • The Genetics of Bipolar Disorder
    Molecular Psychiatry (2008) 13, 742–771 & 2008 Nature Publishing Group All rights reserved 1359-4184/08 $30.00 www.nature.com/mp FEATURE REVIEW The genetics of bipolar disorder: genome ‘hot regions,’ genes, new potential candidates and future directions A Serretti and L Mandelli Institute of Psychiatry, University of Bologna, Bologna, Italy Bipolar disorder (BP) is a complex disorder caused by a number of liability genes interacting with the environment. In recent years, a large number of linkage and association studies have been conducted producing an extremely large number of findings often not replicated or partially replicated. Further, results from linkage and association studies are not always easily comparable. Unfortunately, at present a comprehensive coverage of available evidence is still lacking. In the present paper, we summarized results obtained from both linkage and association studies in BP. Further, we indicated new potential interesting genes, located in genome ‘hot regions’ for BP and being expressed in the brain. We reviewed published studies on the subject till December 2007. We precisely localized regions where positive linkage has been found, by the NCBI Map viewer (http://www.ncbi.nlm.nih.gov/mapview/); further, we identified genes located in interesting areas and expressed in the brain, by the Entrez gene, Unigene databases (http://www.ncbi.nlm.nih.gov/entrez/) and Human Protein Reference Database (http://www.hprd.org); these genes could be of interest in future investigations. The review of association studies gave interesting results, as a number of genes seem to be definitively involved in BP, such as SLC6A4, TPH2, DRD4, SLC6A3, DAOA, DTNBP1, NRG1, DISC1 and BDNF.
    [Show full text]
  • Regulation of HDAC2-PDX1 by RNF125 Defines Pancreatic Cancer Development
    bioRxiv preprint doi: https://doi.org/10.1101/2020.01.06.896555; this version posted January 7, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Regulation of HDAC2-PDX1 by RNF125 defines pancreatic cancer development Erez Hasnis1, Hyungsoo Kim1, Sachin Verma1, Yongmei Feng1, Ronit Almog2, Sivan Matsliah2, Vera Vavinskaya3, Ron Apelbaum2, Offir Ben-Ishay2, David Tuveson4, Rosalie Sears5, Ze’ev A. Ronai1 1Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA; 2Rambam Health Care Campus, Haifa, Israel; 3Department of Pathology, University of California San Diego, La Jolla, CA, USA; 4Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 5Oregon Health and Science University, Portland, OR Keywords: RNF125, pancreatic cancer, PDA, PDX1, NR5A2, HDAC2, acinar, ductal, ADM Correspondence – Ze’ev A Ronai, [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.01.06.896555; this version posted January 7, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract There is an urgent need to define mechanisms underlying pancreatic adenocarcinoma (PDA) development. Our studies of ubiquitin ligases that may underlie PDA development led us to identify and characterize RNF125. We show that RNF125 exhibits nuclear expression in acinar cells, with reduced and largely cytosolic expression in ductal cells, PanIN and PDA specimens. We find that RNF125 interacts with histone deacetylase 2 (HDAC2) and promotes its non- canonical K63-linked ubiquitination. Inhibition of HDAC2 activity by RNF125 resulted in elevated expression of the pancreatic and duodenal homeobox 1 (PDX1).
    [Show full text]
  • A Genome-Wide Screen in Mice to Identify Cell-Extrinsic Regulators of Pulmonary Metastatic Colonisation
    FEATURED ARTICLE MUTANT SCREEN REPORT A Genome-Wide Screen in Mice To Identify Cell-Extrinsic Regulators of Pulmonary Metastatic Colonisation Louise van der Weyden,1 Agnieszka Swiatkowska, Vivek Iyer, Anneliese O. Speak, and David J. Adams Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, United Kingdom ORCID IDs: 0000-0002-0645-1879 (L.v.d.W.); 0000-0003-4890-4685 (A.O.S.); 0000-0001-9490-0306 (D.J.A.) ABSTRACT Metastatic colonization, whereby a disseminated tumor cell is able to survive and proliferate at a KEYWORDS secondary site, involves both tumor cell-intrinsic and -extrinsic factors. To identify tumor cell-extrinsic metastasis (microenvironmental) factors that regulate the ability of metastatic tumor cells to effectively colonize a metastatic tissue, we performed a genome-wide screen utilizing the experimental metastasis assay on mutant mice. colonisation Mutant and wildtype (control) mice were tail vein-dosed with murine metastatic melanoma B16-F10 cells and microenvironment 10 days later the number of pulmonary metastatic colonies were counted. Of the 1,300 genes/genetic B16-F10 locations (1,344 alleles) assessed in the screen 34 genes were determined to significantly regulate pulmonary lung metastatic colonization (15 increased and 19 decreased; P , 0.005 and genotype effect ,-55 or .+55). mutant While several of these genes have known roles in immune system regulation (Bach2, Cyba, Cybb, Cybc1, Id2, mouse Igh-6, Irf1, Irf7, Ncf1, Ncf2, Ncf4 and Pik3cg) most are involved in a disparate range of biological processes, ranging from ubiquitination (Herc1) to diphthamide synthesis (Dph6) to Rho GTPase-activation (Arhgap30 and Fgd4), with no previous reports of a role in the regulation of metastasis.
    [Show full text]
  • A Genome-Wide Screen in Mice to Identify Cell-Extrinsic Regulators of Pulmonary Metastatic Colonisation
    bioRxiv preprint doi: https://doi.org/10.1101/2020.02.10.941401; this version posted February 10, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 A genome-wide screen in mice to identify cell-extrinsic regulators of pulmonary 2 metastatic colonisation 3 4 5 Louise van der Weyden1*, Agnieszka Swiatkowska1, Vivek Iyer1, Anneliese O. Speak1, David J. 6 Adams1 7 8 9 1Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, 10 United Kingdom 11 12 13 *Corresponding author 14 Louise van der Weyden 15 Experimental Cancer Genetics 16 Wellcome Sanger Institute 17 Wellcome Genome Campus 18 Hinxton 19 Cambridge 20 CB10 1SA 21 United Kingdom 22 Tel: +44-1223-834-244 23 Email: [email protected] 24 25 26 KEYWORDS: metastasis, metastatic colonisation, microenvironment, B16-F10, lung, mutant, 27 mouse. 28 29 30 31 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.02.10.941401; this version posted February 10, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 32 ABSTRACT 33 34 Metastatic colonisation, whereby a disseminated tumour cell is able to survive and 35 proliferate at a secondary site, involves both tumour cell-intrinsic and -extrinsic factors.
    [Show full text]
  • Dynamic Molecular Changes During the First Week of Human Life Follow A
    ARTICLE https://doi.org/10.1038/s41467-019-08794-x OPEN Dynamic molecular changes during the first week of human life follow a robust developmental trajectory Amy H. Lee 1, Casey P. Shannon 2, Nelly Amenyogbe3,25, Tue B. Bennike 4,5,6, Joann Diray-Arce5,6, Olubukola T. Idoko7,8, Erin E. Gill1, Rym Ben-Othman9, William S. Pomat10, Simon D. van Haren5,6, Kim-Anh Lê Cao 11, Momoudou Cox7, Alansana Darboe 7, Reza Falsafi1, Davide Ferrari11, Daniel J. Harbeson3, Daniel He 2, Cai Bing9, Samuel J. Hinshaw1,12, Jorjoh Ndure7, Jainaba Njie-Jobe7, Matthew A. Pettengill5, Peter C. Richmond13,14, Rebecca Ford10, Gerard Saleu10, Geraldine Masiria10, 1234567890():,; John Paul Matlam10, Wendy Kirarock10, Elishia Roberts7, Mehrnoush Malek15, Guzmán Sanchez-Schmitz5,6, Amrit Singh 2,16, Asimenia Angelidou5,6,17, Kinga K. Smolen5,6, The EPIC Consortium#, Ryan R. Brinkman15,18, Al Ozonoff5,6,19, Robert E.W. Hancock 1, Anita H.J. van den Biggelaar14, Hanno Steen 4,5,7, Scott J. Tebbutt 2,20,21, Beate Kampmann7,22, Ofer Levy 5,6,23 & Tobias R. Kollmann 3,9,25 Systems biology can unravel complex biology but has not been extensively applied to human newborns, a group highly vulnerable to a wide range of diseases. We optimized methods to extract transcriptomic, proteomic, metabolomic, cytokine/chemokine, and single cell immune phenotyping data from <1 ml of blood, a volume readily obtained from newborns. Indexing to baseline and applying innovative integrative computational methods reveals dramatic chan- ges along a remarkably stable developmental trajectory over the first week of life. This is most evident in changes of interferon and complement pathways, as well as neutrophil- associated signaling.
    [Show full text]
  • W O 2019/079360 a L 25 April 2019 (25.04.2019) W 1P O PCT
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International Publication Date W O 2019/079360 A l 25 April 2019 (25.04.2019) W 1P O PCT (51) International Patent Classification: (72) Inventors; and G01N 33/48 (2006.01) G01N 33/53 (2006.01) (71) Applicants: KEAN, Leslie [US/US]; c/o 818 Stewart St, Suite 603, Seattle, Washington 98101 (US). COLONNA, (21) International Application Number: Lucrezia [US/US]; c/o 818 Stewart St, Suite 603, Seattle, PCT/US2018/056166 Washington 98101 (US). CARROLL, Shaina [US/US]; (22) International Filing Date: c/o 77 Massachusetts Avenue, Cambridge, Massachusetts 16 October 2018 (16. 10.2018) 02139 (US). (25) Filing Language: English (72) Inventors: SHALEK, Alexander K.; c/o 77 Massachu¬ setts Avenue, Cambridge, Massachusetts 02139 (US). ZIE- (26) Publication Language: English GLER, Carly; c/o 77 Massachusetts Avenue, Cambridge, (30) Priority Data: Massachusetts 02139 (US). 62/573,015 16 October 2017 (16. 10.2017) US (74) Agent: SCHER, Michael B. et al.; Johnson, Marcou & (71) Applicants: MASSACHUSETTS INSTITUTE OF Isaacs, LLC, P.O. Bo 691, Hoschton, Georgia 30548 (US). TECHNOLOGY [US/US]; 77 Massachusetts Av¬ (81) Designated States (unless otherwise indicated, for every enue, Cambridge, Massachusetts 02139 (US). SEAT¬ kind of national protection available): AE, AG, AL, AM, TLE CHILDREN'S HOSPITAL DBA SEATTLE AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CHILDREN'S RESEARCH INSTITUTE [US/US]; 818 CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, Stewart St, Suite 603, Seattle, Washington 98101 (US).
    [Show full text]
  • Nicole Soranzo [email protected] Vijay G. Sankaran [email protected]
    The Polygenic and Monogenic Basis of Blood Traits and Diseases Dragana Vuckovic1,2 *, Erik L. Bao3,4 *, Parsa Akbari5,2,6,1 *, Caleb A. Lareau3,4 *, Abdou Mousas7, Tao Jiang5,8, Ming-Huei Chen9,10, Laura M. Raffield11, Manuel Tardaguila1, Jennifer E. Huffman12, Scott C. Ritchie13,14,5,15,8, Karyn Megy16,17,18, Hannes Ponstingl19, Christopher J. Penkett17,16, Patrick K. Albers19, Emilie M. Wigdor1, Saori Sakaue20,21, Arden Moscati22, Regina Manansala23, Ken Sin Lo7, Huijun Qian24, Masato Akiyama21,25, Traci M. Bartz26, Yoav Ben-Shlomo27, Andrew Beswick28, Jette Bork-Jensen29, Erwin P. Bottinger30,22, Jennifer A. Brody31, Frank J.A. van Rooij32, Kumaraswamy N. Chitrala33, Kelly Cho34,35,36, Hélène Choquet37, Adolfo Correa38, John Danesh5,39,2,1,8,40, Emanuele Di Angelantonio5,39,2,1,8,40, Niki Dimou41,42, Jingzhong Ding43, Paul Elliott44,45,46,47,48, Tõnu Esko4, Michele K. Evans33, Stephan B. Felix49,50, James S. Floyd31,51, Linda Broer52, Niels Grarup29, Michael H. Guo4,53, Andreas Greinacher54, Jeff Haessler55, Torben Hansen29, Joanna M. M. Howson5,8, Wei Huang56, Eric Jorgenson37, Tim Kacprowski57,58,50, Mika Kähönen59,60, Yoichiro Kamatani21,61, Masahiro Kanai21,62, Savita Karthikeyan5, Fotis Koskeridis42, Leslie A. Lange63, Terho Lehtimäki64,65, Allan Linneberg66,67, Yongmei Liu68, Leo-Pekka Lyytikäinen64,65, Ani Manichaikul69, Koichi Matsuda70, Karen L. Mohlke11, Nina Mononen64,65, Yoshinori Murakami71, Girish N. Nadkarni22, Kjell Nikus72,73, Nathan Pankratz74, Oluf Pedersen29, Michael Preuss22, Bruce M. Psaty75,31,76,77, Olli T. Raitakari78,79,80, Stephen S. Rich69, Benjamin A.T. Rodriguez9,10, Jonathan D. Rosen81, Jerome I. Rotter82, Petra Schubert34, Cassandra N.
    [Show full text]